FDA Awards Grants for the Study of TB to Create Better Diagnosis, Treatment and Prevention

The grants include finding biomarkers to target vaccines and creating a repository of specimens to gather information for research. Six physicians were selected and each plays a role with a specific area of research. TB has been a long time disease spread throughout the air and years ago there patients were placed in institutions to avoid spreading of the disease as TB is not new and has been amongst society for years. The press release link below names the physicians and each area of research for their investigations. BD

FDA awards nearly $3 million for TB research
Awards support critical public health need for TB drug development

The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will help with the diagnosis, treatment, and prevention of tuberculosis (TB).

TB remains a major public health challenge with an increasing prevalence worldwide. Two recent articles published by FDA’s Office of Critical Path Programs note that advances are urgently needed in TB drug development to shorten therapy and to treat drug-resistant disease.

“FDA recognized an urgent need for the engagement and leadership of public health institutions to promote this critical, but neglected, area of medical therapeutics,” said FDA Commissioner Margaret A. Hamburg, M.D.

FDA awards nearly $3 million for TB research